{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:08:06Z","timestamp":1791047286087,"version":"4.1.0"},"reference-count":35,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Human T-cell leukemia virus type I (HTLV-I) is a causative agent of neoplastic disease, adult T-cell leukemia (ATL). Although the encoding viral proteins play an important role in oncogenesis, the role of the HTLV-I proviral integration site remains unsolved. We determined the integration sites of HTLV-I proviruses in ATL cells and HTLV-I\u2013infected cells in asymptomatic carriers. In carrier and ATL cells, HTLV-I provirus was integrated into the transcriptional unit at frequencies of 26.8% (15\/56) and 33.9% (20\/59), respectively, which were equivalent to the frequency calculated based on random integration (33.2%). In addition, HTLV-I provirus was prone to integration near the transcriptional start sites in leukemic cells (P = .006), and the transcriptional direction of the provirus was in accordance with that of integrated cellular genes in 70% of cases. More importantly, the integration sites in the carrier cells favored the alphoid repetitive sequences (11\/56; 20%) whereas in leukemic cells they disfavored these sequences (2\/59; 3.4%). Taken together, during natural course from carrier to onset of ATL, HTLV-I\u2013infected cells with integration sites favorable for viral gene transcription are susceptible to malignant transformation due to increased viral gene expression.<\/jats:p>","DOI":"10.1182\/blood-2004-11-4350","type":"journal-article","created":{"date-parts":[[2005,4,19]],"date-time":"2005-04-19T20:24:41Z","timestamp":1113942281000},"page":"1048-1053","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":65,"title":["Preferential selection of human T-cell leukemia virus type I provirus integration sites in leukemic versus carrier states"],"prefix":"10.1182","volume":"106","author":[{"given":"Keitarou","family":"Doi","sequence":"first","affiliation":[{"name":"From the Laboratory of Virus Immunology, Institute for Virus Research, Kyoto University, Kyoto, Japan; Laboratory of Molecular Technology, National Cancer Institute-Frederick, Frederick, MD; and the Department of Laboratory Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Wu","sequence":"additional","affiliation":[{"name":"From the Laboratory of Virus Immunology, Institute for Virus Research, Kyoto University, Kyoto, Japan; Laboratory of Molecular Technology, National Cancer Institute-Frederick, Frederick, MD; and the Department of Laboratory Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"From the Laboratory of Virus Immunology, Institute for Virus Research, Kyoto University, Kyoto, Japan; Laboratory of Molecular Technology, National Cancer Institute-Frederick, Frederick, MD; and the Department of Laboratory Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichirou","family":"Yasunaga","sequence":"additional","affiliation":[{"name":"From the Laboratory of Virus Immunology, Institute for Virus Research, Kyoto University, Kyoto, Japan; Laboratory of Molecular Technology, National Cancer Institute-Frederick, Frederick, MD; and the Department of Laboratory Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorifumi","family":"Satou","sequence":"additional","affiliation":[{"name":"From the Laboratory of Virus Immunology, Institute for Virus Research, Kyoto University, Kyoto, Japan; Laboratory of Molecular Technology, National Cancer Institute-Frederick, Frederick, MD; and the Department of Laboratory Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Okayama","sequence":"additional","affiliation":[{"name":"From the Laboratory of Virus Immunology, Institute for Virus Research, Kyoto University, Kyoto, Japan; Laboratory of Molecular Technology, National Cancer Institute-Frederick, Frederick, MD; and the Department of Laboratory Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisato","family":"Nosaka","sequence":"additional","affiliation":[{"name":"From the Laboratory of Virus Immunology, Institute for Virus Research, Kyoto University, Kyoto, Japan; Laboratory of Molecular Technology, National Cancer Institute-Frederick, Frederick, MD; and the Department of Laboratory Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"From the Laboratory of Virus Immunology, Institute for Virus Research, Kyoto University, Kyoto, Japan; Laboratory of Molecular Technology, National Cancer Institute-Frederick, Frederick, MD; and the Department of Laboratory Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021223392600000_REF1","doi-asserted-by":"crossref","unstructured":"Hayward WS, Neel BG, Astrin SM. Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature. 1981;290: 475-480.","DOI":"10.1038\/290475a0"},{"key":"2020021223392600000_REF2","doi-asserted-by":"crossref","unstructured":"Nusse R, Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell. 1982;31: 99-109.","DOI":"10.1016\/0092-8674(82)90409-3"},{"key":"2020021223392600000_REF3","doi-asserted-by":"crossref","unstructured":"Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell. 2002;110: 521-529.","DOI":"10.1016\/S0092-8674(02)00864-4"},{"key":"2020021223392600000_REF4","doi-asserted-by":"crossref","unstructured":"Wu X, Li Y, Crise B, Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science. 2003;300: 1749-1751.","DOI":"10.1126\/science.1083413"},{"key":"2020021223392600000_REF5","doi-asserted-by":"crossref","unstructured":"Mitchell RS, Beitzel BF, Schroder AR, et al. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2004;2: 1127-1137.","DOI":"10.1371\/journal.pbio.0020234"},{"key":"2020021223392600000_REF6","doi-asserted-by":"crossref","unstructured":"Matsuoka M. Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene. 2003;22: 5131-5140.","DOI":"10.1038\/sj.onc.1206551"},{"key":"2020021223392600000_REF7","doi-asserted-by":"crossref","unstructured":"Yoshida M, Suzuki T. HTLV type 1 Tax oncoprotein binds to DNA topoisomerase I and inhibits its catalytic activity. AIDS Res Hum Retroviruses. 2000;16: 1639-1645.","DOI":"10.1089\/08892220050193083"},{"key":"2020021223392600000_REF8","doi-asserted-by":"crossref","unstructured":"Franchini G, Fukumoto R, Fullen JR. T-cell control by human T-cell leukemia\/lymphoma virus type 1. Int J Hematol. 2003;78: 280-296.","DOI":"10.1007\/BF02983552"},{"key":"2020021223392600000_REF9","doi-asserted-by":"crossref","unstructured":"Suzuki T, Uchida-Toita M, Yoshida M. Tax protein of HTLV-1 inhibits CBP\/p300-mediated transcription by interfering with recruitment of CBP\/p300 onto DNA element of E-box or p53 binding site. Oncogene. 1999;18: 4137-4143.","DOI":"10.1038\/sj.onc.1202766"},{"key":"2020021223392600000_REF10","doi-asserted-by":"crossref","unstructured":"Suzuki T, Kitao S, Matsushime H, Yoshida M. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J. 1996;15: 1607-1614.","DOI":"10.1002\/j.1460-2075.1996.tb00505.x"},{"key":"2020021223392600000_REF11","doi-asserted-by":"crossref","unstructured":"Jin DY, Spencer F, Jeang KT. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell. 1998;93: 81-91.","DOI":"10.1016\/S0092-8674(00)81148-4"},{"key":"2020021223392600000_REF12","doi-asserted-by":"crossref","unstructured":"Ozawa T, Itoyama T, Sadamori N, et al. Rapid isolation of viral integration site reveals frequent integration of HTLV-1 into expressed loci. J Hum Genet. 2004;49: 154-165.","DOI":"10.1007\/s10038-004-0126-7"},{"key":"2020021223392600000_REF13","doi-asserted-by":"crossref","unstructured":"Hanai S, Nitta T, Shoda M, et al. Integration of human T-cell leukemia virus type 1 in genes of leukemia cells of patients with adult T-cell leukemia. Cancer Sci. 2004;95: 306-310.","DOI":"10.1111\/j.1349-7006.2004.tb03207.x"},{"key":"2020021223392600000_REF14","doi-asserted-by":"crossref","unstructured":"Kent WJ. BLAT\u2014the BLAST-like alignment tool. Genome Res. 2002;12: 656-664.","DOI":"10.1101\/gr.229202"},{"key":"2020021223392600000_REF15","doi-asserted-by":"crossref","unstructured":"Seiki M, Eddy R, Shows TB, Yoshida M. Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells. Nature. 1984;309: 640-642.","DOI":"10.1038\/309640a0"},{"key":"2020021223392600000_REF16","doi-asserted-by":"crossref","unstructured":"Ohshima K, Ohgami A, Matsuoka M, et al. Random integration of HTLV-1 provirus: increasing chromosomal instability. Cancer Lett. 1998;132: 203-212.","DOI":"10.1016\/S0304-3835(98)00188-8"},{"key":"2020021223392600000_REF17","doi-asserted-by":"crossref","unstructured":"Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409: 860-921.","DOI":"10.1038\/35057062"},{"key":"2020021223392600000_REF18","doi-asserted-by":"crossref","unstructured":"Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science. 2001;291: 1304-1351.","DOI":"10.1126\/science.1058040"},{"key":"2020021223392600000_REF19","doi-asserted-by":"crossref","unstructured":"Tamiya S, Matsuoka M, Etoh K, et al. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood. 1996;88: 3065-3073.","DOI":"10.1182\/blood.V88.8.3065.bloodjournal8883065"},{"key":"2020021223392600000_REF20","doi-asserted-by":"crossref","unstructured":"Kubota S, Furuta RA, Siomi H, Maki M, Hatanaka M. Analysis of a novel defective HTLV-I provirus and detection of a new HTLV-I-induced cellular transcript. FEBS Lett. 1995;375: 31-36.","DOI":"10.1016\/0014-5793(95)01166-C"},{"key":"2020021223392600000_REF21","doi-asserted-by":"crossref","unstructured":"Choo KH, Vissel B, Nagy A, Earle E, Kalitsis P. A survey of the genomic distribution of alpha satellite DNA on all the human chromosomes, and derivation of a new consensus sequence. Nucleic Acids Res. 1991;19: 1179-1182.","DOI":"10.1093\/nar\/19.6.1179"},{"key":"2020021223392600000_REF22","doi-asserted-by":"crossref","unstructured":"Han Y, Lassen K, Monie D, et al. Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. J Virol. 2004;78: 6122-6133.","DOI":"10.1128\/JVI.78.12.6122-6133.2004"},{"key":"2020021223392600000_REF23","doi-asserted-by":"crossref","unstructured":"Jordan A, Bisgrove D, Verdin E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 2003;22: 1868-1877.","DOI":"10.1093\/emboj\/cdg188"},{"key":"2020021223392600000_REF24","doi-asserted-by":"crossref","unstructured":"Bangham CR. Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control. Int J Hematol. 2003;78: 297-303.","DOI":"10.1007\/BF02983553"},{"key":"2020021223392600000_REF25","doi-asserted-by":"crossref","unstructured":"Kannagi M, Harada S, Maruyama I, et al. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol. 1991;3: 761-767.","DOI":"10.1093\/intimm\/3.8.761"},{"key":"2020021223392600000_REF26","doi-asserted-by":"crossref","unstructured":"Mulligan RC. The basic science of gene therapy. Science. 1993;260: 926-932.","DOI":"10.1126\/science.8493530"},{"key":"2020021223392600000_REF27","doi-asserted-by":"crossref","unstructured":"Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;272: 263-267.","DOI":"10.1126\/science.272.5259.263"},{"key":"2020021223392600000_REF28","doi-asserted-by":"crossref","unstructured":"Casolari JM, Brown CR, Komili S, West J, Hieronymus H, Silver PA. Genome-wide localization of the nuclear transport machinery couples transcriptional status and nuclear organization. Cell. 2004;117: 427-439.","DOI":"10.1016\/S0092-8674(04)00448-9"},{"key":"2020021223392600000_REF29","doi-asserted-by":"crossref","unstructured":"Ariumi Y, Shimotohno K, Noda M, Hatanaka M. Characterization of the internal promoter of human T-cell leukemia virus type I. FEBS Lett. 1998;423: 25-30.","DOI":"10.1016\/S0014-5793(98)00051-9"},{"key":"2020021223392600000_REF30","doi-asserted-by":"crossref","unstructured":"Grassmann R, Dengler C, Muller-Fleckenstein I, et al. Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. Proc Natl Acad Sci U S A. 1989;86: 3351-3355.","DOI":"10.1073\/pnas.86.9.3351"},{"key":"2020021223392600000_REF31","doi-asserted-by":"crossref","unstructured":"Akagi T, Ono H, Shimotohno K. Characterization of T cells immortalized by Tax1 of human T-cell leukemia virus type 1. Blood. 1995;86: 4243-4249.","DOI":"10.1182\/blood.V86.11.4243.bloodjournal86114243"},{"key":"2020021223392600000_REF32","doi-asserted-by":"crossref","unstructured":"Koiwa T, Hamano-Usami A, Ishida T, et al. 5\u2032-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J Virol. 2002;76: 9389-9397.","DOI":"10.1128\/JVI.76.18.9389-9397.2002"},{"key":"2020021223392600000_REF33","doi-asserted-by":"crossref","unstructured":"Furukawa Y, Kubota R, Tara M, Izumo S, Osame M. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia. Blood. 2001;97: 987-993.","DOI":"10.1182\/blood.V97.4.987"},{"key":"2020021223392600000_REF34","doi-asserted-by":"crossref","unstructured":"Takeda S, Maeda M, Morikawa S, et al. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer. 2004;109: 559-567.","DOI":"10.1002\/ijc.20007"},{"key":"2020021223392600000_REF35","doi-asserted-by":"crossref","unstructured":"Kannagi M, Ohashi T, Harashima N, Hanabuchi S, Hasegawa A. Immunological risks of adult T-cell leukemia at primary HTLV-I infection. Trends Microbiol. 2004;12: 346-352.","DOI":"10.1016\/j.tim.2004.05.005"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/3\/1048\/1711709\/zh801505001048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/3\/1048\/1711709\/zh801505001048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T23:39:39Z","timestamp":1581550779000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/3\/1048\/21865\/Preferential-selection-of-human-Tcell-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,1]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,8,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-11-4350","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,1]]}}}